Autoantibody biomarkers for the detection of serous ovarian cancer.
about
Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.Advances in cell-free protein array methods.Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer.Tumor-associated auto-antibodies as early detection markers for ovarian cancer? A prospective evaluation.
P2860
Autoantibody biomarkers for the detection of serous ovarian cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Autoantibody biomarkers for the detection of serous ovarian cancer.
@en
Autoantibody biomarkers for the detection of serous ovarian cancer.
@nl
type
label
Autoantibody biomarkers for the detection of serous ovarian cancer.
@en
Autoantibody biomarkers for the detection of serous ovarian cancer.
@nl
prefLabel
Autoantibody biomarkers for the detection of serous ovarian cancer.
@en
Autoantibody biomarkers for the detection of serous ovarian cancer.
@nl
P2093
P2860
P921
P1433
P1476
Autoantibody biomarkers for the detection of serous ovarian cancer.
@en
P2093
Allison F Vitonis
Benjamin A Katchman
Daniel W Cramer
Diego Chowell
Garrick Wallstrom
Karen S Anderson
P2860
P304
P356
10.1016/J.YGYNO.2017.04.005
P407
P577
2017-04-17T00:00:00Z